Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines
Sponsor: Qualia Life Sciences
Summary
This open-label pilot study includes adults aged 45 to 79 residing in the United States. The study will last 7 days. Participants will provide blood samples via an at-home finger-prick kit at baseline and day 7 and complete electronic surveys on health indicators at baseline, and days 3 and 7. All procedures are conducted remotely, with no in-person visits, to collect real-world evidence.
Key Details
Gender
All
Age Range
45 Years - 79 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-05-12
Completion Date
2025-05-18
Last Updated
2025-05-01
Healthy Volunteers
Yes
Conditions
Interventions
Qualia Senolytic
Qualia Senolytic manufactured by Qualia Life Science
Locations (1)
Qualia Life Sciences
Carlsbad, California, United States